ADA has all hype anti-diabetic curing medications

A wide range of anti-diabetic medications will be soon in the market, which are more effective as compared to the new drugs and may aid to hinder the radical emergence of this detrimental sugary disease.

DC, WA (prHWY.com) June 15, 2012 - 15 June 2012,USA (Zeepharmacy.com):Diabetes is one such clinical condition which is paving its way to the top position by affecting around 130 millions of individuals in the world. And, hence to provide the patients with better medical aids various pharmaceutical giants are creating better and bigger opportunities for drug manufacturing.
The recent ADA (American Drug Association) conference that was conducted in Philadelphia for over a week is a platform for releasing as well as talking about the research studies. The top pharmaceutical companies that presented their drug information related to diabetes include Sanofi, Merck, Novo Nordisk and Amylin.

Diabetes is being currently regarded as an epidemic disease condition in U.S. and hence, every pharmaceutical company is trying to prove their respective anti-diabetic drug as an effective and safe medication. They are also putting their step forward for inventing new treatment options along with in-depth studies of their currently available medications in the market.
Lantus, an anti-diabetic drug manufactured by Sanofi pharmaceutical has been proved to be more efficient than its counterdrug Januvia, produced by Merck in ameliorating blood sugar levels. Lantus reduced HbA1C levels by 1.7%, while Januvia caused only 1.1% reduction.
Novo Nordisk's degludec showed a 36% in blood glucose levels at night compared to Lantus. Victoza, another anti-diabetic medication produced by this company caused a significant reduction in HbA1c levels in the diabetic individuals as compared to other medications such as Januvia of Merck and Byetta of Amylin.
While, Amylin's Byetta, non-insulin once daily injectable drug when taken with metformin showed HbA1C levels to reduce by around 7% as related to 33% patients on Amaryl and metformin.
Whereas Bydureon, a once a week anti-diabetic treatment medication produced by Amylin and Alkermes proved a significant reduction in fasting as well as nighttime HbA1C levels irrespective of their hypertension and weight issues.
For more: http://www.zeepharmacy.com/generic-cialis.html
Zeepharmacy.com
1600 Pennsylvania Ave, Washington, DC, USA - 20002

###

Tag Words: online generic pharmacy, generic cialis online

Categories: Health

Press Release Contact
http://www.zeepharmacy.com

Link To This Press Release:

URL HTML Code